About the study

Information about how the study will work and what we aim to find.

How the study will work

We are planning to include 592 people with kidney disease at 20 hospitals across the UK. People who take part in the trial will be allocated to one of two groups.

Group 1 will receive usual NHS care.

Group 2 will receive the usual care, plus the following:

• Potential donor identification: A meeting with a Living Donor Kidney Transplant (LDKT) nurse specialist to elicit any personal barriers to LDKT, and to discuss their network of family and friends and their possible suitability for donation.
• NHS outreach to potential donors: A letter from a hospital doctor to their family and friends about kidney donation and how to donate.
• Home-based family engagement and education: A LDKT nurse specialist and a kidney donor visit the participant and their family at home, to talk about kidney disease, transplantation and what it is like to donate a kidney.

What we hope to find

The ASK trial will test whether the developed support and outreach service is effective at helping people to receive a LDKT, if it is cost-effective, and if it is something the NHS should provide. At the end of the trial, we will see if people in Group 2 are more likely to have a LDKT than people in Group 1.